γ-oryzanol の経口投与がHDL-cholesterol におよぼす影響
1980 年 8 巻 2 号 p. 405-409
詳細
1980 年 8 巻 2 号 p. 405-409
42 diabetic patient with hyperlipidemia were treated with γ-oryzanol of 300mg/day for 16 weeks, and the changes of serum lipid levels was followed.
Significant reduction of cholesterol, triglyceride, malondialdehyde and atherogenic index was appeared following medication as 270 to 238 mg/dl (p was less than 0.01), 250 to 173mg/dl (p was less than 0.05), 3.6 to 2.1n mol/ml (p was less than 0.01) and 5.0 to 3.4 (p was less than 0.001), respectively.
The HDL-cholesterol increased significantly from 47 to 56mg/dl (p was less than 0.001) in both hypo and hyper HDL-cholesterolemic groups.
